Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study
托瑞普利单抗联合乐伐替尼和吉西他滨方案作为晚期肝内胆管癌的一线治疗方案前景可观：一项单中心、单臂 II 期研究
期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-023-01317-7
Shi, Guo-Ming; Huang, Xiao-Yong; Wu, Dong; Sun, Hui-Chuan; Liang, Fei; Ji, Yuan; Chen, Yi; Yang, Guo-Huan; Lu, Jia-Cheng; Meng, Xian-Long; Wang, Xin-Ying; Sun, Lei; Ge, Ning-Ling; Huang, Xiao-Wu; Qiu, Shuang-Jian; Yang, Xin-Rong; Gao, Qiang; He, Yi-Feng; Xu, Yang; Sun, Jian; Ren, Zheng-Gang; Fan, Jia; Zhou, Jian
